| scholarly article | Q13442814 |
| P2093 | author name string | Michael E Pichichero | |
| M Nadeem Khan | |||
| Qingfu Xu | |||
| P2860 | cites work | Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae | Q24548650 |
| The role of pneumolysin in pneumococcal pneumonia and meningitis | Q24684269 | ||
| Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance | Q26851961 | ||
| Co-infection subverts mucosal immunity in the upper respiratory tract | Q27002952 | ||
| The host immune dynamics of pneumococcal colonization: implications for novel vaccine development | Q28084920 | ||
| Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study | Q28270868 | ||
| Desert dust exposure is associated with increased risk of asthma hospitalization in children | Q28391279 | ||
| Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial. | Q40211674 | ||
| Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study | Q40215132 | ||
| Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. | Q40324555 | ||
| Effect of dexamethasone on the efficacy of daptomycin in the therapy of experimental pneumococcal meningitis. | Q41379406 | ||
| Understanding the ontogeny of the immune system to promote immune-mediated health for life | Q41440875 | ||
| Pneumococcal PspA and PspC proteins: potential vaccine candidates for experimental otitis media | Q42083281 | ||
| Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model | Q42171376 | ||
| TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses | Q42216579 | ||
| Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection | Q42230443 | ||
| Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection | Q42250175 | ||
| The immune response to pneumococcal proteins during experimental human carriage | Q42944608 | ||
| Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage. | Q43519933 | ||
| T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease | Q43645903 | ||
| IL-17: important for host defense, autoimmunity, and allergy? | Q43806029 | ||
| Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae | Q44445679 | ||
| Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model | Q45140053 | ||
| Long-term impairment of Streptococcus pneumoniae lung clearance is observed after initial infection with influenza A virus but not human metapneumovirus in mice | Q45368154 | ||
| Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla | Q45739613 | ||
| Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children | Q46947680 | ||
| IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection | Q47371295 | ||
| Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A. | Q48015358 | ||
| Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model | Q50270301 | ||
| Bacterial lipoproteins differentially regulate human primary and memory CD4+ T and B cell responses to pneumococcal protein antigens through Toll-like receptor 2. | Q51057635 | ||
| Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. | Q51141744 | ||
| Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis. | Q53641472 | ||
| Changes in uterine blood flow during human pregnancy. | Q54333958 | ||
| Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. | Q54627231 | ||
| The dual nature of TH17 cells: shifting the focus to function | Q56607716 | ||
| Public-health impact of outdoor and traffic-related air pollution: a European assessment | Q56967181 | ||
| The NLRP3 Inflammasome Is Differentially Activated by Pneumolysin Variants and Contributes to Host Defense in Pneumococcal Pneumonia | Q58286289 | ||
| Influenza Infection Leads to Increased Susceptibility to Subsequent Bacterial Superinfection by Impairing NK Cell Responses in the Lung | Q59747080 | ||
| Adherence of Streptococcus pneumoniae to polystyrene plates, effect of serum on adhesion, and virulence in the gerbil otitis media model | Q80510063 | ||
| Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage | Q81098313 | ||
| Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children | Q84067441 | ||
| Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine | Q85350626 | ||
| Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model | Q87680192 | ||
| Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis | Q28728017 | ||
| Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada | Q28740857 | ||
| A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
| Insights into the interaction between influenza virus and pneumococcus | Q30355570 | ||
| Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae | Q30429002 | ||
| Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies | Q33312893 | ||
| Interleukin-17A mediates acquired immunity to pneumococcal colonization | Q33370537 | ||
| Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults | Q33525683 | ||
| The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae | Q33554796 | ||
| Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense | Q33788735 | ||
| Potential role for mucosally active vaccines against pneumococcal pneumonia | Q33792681 | ||
| A comparative study of thin-section CT findings between seasonal influenza virus pneumonia and Streptococcus pneumoniae pneumonia | Q33823308 | ||
| CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization | Q33935327 | ||
| Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. | Q33996628 | ||
| Pneumococcal virulence factors: structure and function | Q34010335 | ||
| Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature | Q34048678 | ||
| Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge | Q34057765 | ||
| Unbalanced Neonatal CD4(+) T-Cell Immunity | Q34091987 | ||
| Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines | Q34109088 | ||
| Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents. | Q34146281 | ||
| Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease | Q34149169 | ||
| The role of environmental factors in modulating immune responses in early life | Q34169396 | ||
| Protein carriers of conjugate vaccines: characteristics, development, and clinical trials | Q34170021 | ||
| Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus | Q34261558 | ||
| Variation in protection by BCG: implications of and for heterologous immunity | Q34288541 | ||
| Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens | Q34484575 | ||
| Viral and bacterial interactions in the upper respiratory tract | Q34550727 | ||
| Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children | Q34577705 | ||
| Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection | Q34589265 | ||
| A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection | Q34594671 | ||
| Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae | Q34595710 | ||
| Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung | Q34649770 | ||
| An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner | Q34736385 | ||
| Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection | Q34762735 | ||
| A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae | Q37333825 | ||
| Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis | Q37335682 | ||
| Epigenetic control of T-helper-cell differentiation | Q37371624 | ||
| Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein | Q37635127 | ||
| Booster vaccinations: can immunologic memory outpace disease pathogenesis? | Q37637580 | ||
| Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines | Q37663184 | ||
| Pattern recognition receptor-mediated cytokine response in infants across 4 continents. | Q37672021 | ||
| The mucosal immune system of the respiratory tract | Q38006223 | ||
| Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? | Q38008471 | ||
| Mouse models of otitis media: strengths and limitations | Q38015763 | ||
| A century of pneumococcal vaccination research in humans | Q38033704 | ||
| Pneumococcal vaccine and opsonic pneumococcal antibody. | Q38105255 | ||
| Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials | Q38171263 | ||
| Review: current and new generation pneumococcal vaccines | Q38223460 | ||
| Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo | Q38311242 | ||
| New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine | Q38363735 | ||
| Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis | Q39023214 | ||
| Genetic conjugation of components in two pneumococcal fusion protein vaccines enhances paediatric mucosal immune responses | Q39037134 | ||
| Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. | Q39392994 | ||
| The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. | Q39910189 | ||
| Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves | Q40128510 | ||
| Pneumolysin: a double-edged sword during the host-pathogen interaction | Q34824489 | ||
| Next generation pneumococcal vaccines | Q35028495 | ||
| Dynamics of nasopharyngeal colonization by potential respiratory pathogens | Q35056169 | ||
| The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition | Q35068763 | ||
| Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement | Q35097094 | ||
| Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node | Q35115579 | ||
| Replication of type 5 adenovirus promotes middle ear infection by Streptococcus pneumoniae in the chinchilla model of otitis media | Q35132505 | ||
| Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection | Q35220396 | ||
| Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection | Q35530474 | ||
| Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children | Q35531214 | ||
| Immunological mechanisms of vaccination | Q35659533 | ||
| Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
| Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution | Q35771351 | ||
| Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial | Q35783918 | ||
| Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children | Q35811715 | ||
| Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children | Q35887453 | ||
| Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children | Q35915846 | ||
| Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country | Q36013814 | ||
| Neonatal innate TLR-mediated responses are distinct from those of adults. | Q36015806 | ||
| Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury | Q36018158 | ||
| Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage | Q36018177 | ||
| Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae Serotype 20 strains: discovery of a new pneumococcal serotype | Q36201961 | ||
| Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans | Q36376010 | ||
| Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly | Q36511529 | ||
| Nasopharyngeal bacterial interactions in children | Q36574329 | ||
| Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). | Q36724239 | ||
| Variation between Populations in the Innate Immune Response to Vaccine Adjuvants | Q36733384 | ||
| Innate immunity of the newborn: basic mechanisms and clinical correlates | Q36800979 | ||
| Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children | Q36920037 | ||
| Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae | Q37111830 | ||
| CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens | Q37184360 | ||
| Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice | Q37241352 | ||
| CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice | Q37264678 | ||
| Animal models of Streptococcus pneumoniae disease | Q37293669 | ||
| IL-22 and inflammation: leukin' through a glass onion | Q37328260 | ||
| P433 | issue | 1 | |
| P921 | main subject | Streptococcus pneumoniae | Q221179 |
| P304 | page(s) | 194-205 | |
| P577 | publication date | 2015-11-05 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | Next generation protein based Streptococcus pneumoniae vaccines | |
| P478 | volume | 12 |
| Q64119526 | A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Challenge |
| Q92437434 | Antigen delivery format variation and formulation stability through use of a hybrid vector |
| Q57150829 | Assessing the function of pneumococcal neuraminidases NanA, NanB and NanC in in vitro and in vivo lung infection models using monoclonal antibodies |
| Q90105034 | Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy |
| Q47658958 | Development of pneumococcal vaccines over the last 10 years |
| Q47269510 | Evaluation of protective efficacy of selected immunodominant B-cell epitopes within virulent surface proteins of S. Pneumoniae. |
| Q89662604 | How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018 |
| Q90366012 | Humoral response to a 13-valent pneumococcal conjugate vaccine in kidney transplant recipients |
| Q50199957 | Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization |
| Q58596157 | Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation |
| Q41990743 | Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life. |
| Q40053752 | Modeling Specific Antibody Responses to Natural Immunization to Predict a Correlate of Protection Against Infection Before Commencing a Clinical Vaccine Trial |
| Q89068515 | Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen |
| Q89407998 | Novel vaccines: Technology and development |
| Q47410739 | Pneumococcal whole-cell and protein-based vaccines: changing the paradigm |
| Q90290490 | Polyamine Synthesis Effects Capsule Expression by Reduction of Precursors in Streptococcus pneumoniae |
| Q39147459 | Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection |
| Q58698200 | PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae |
| Q58586401 | Role of Inflammatory Risk Factors in the Pathogenesis of |
| Q38819027 | Strategies to develop vaccines of pediatric interest |
| Q47576940 | The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza |
| Q40423092 | Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model |
| Q94545406 | Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives |
Search more.